Correlation Analysis
Eli Lilly & Co. vs Veralto Corporation
LLY vs VLTO
+0.547
Moderate positive
When one moves up, the other tends to follow.
Eli Lilly & Co.
↗LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap 828.2B · 50,000 employees
Veralto Corporation
↗VLTO
Veralto is a diversified industrial firm organized into two segments: water quality, product quality, and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.5 billion in revenue in 2025.
Market cap 21.8B · 17,000 employees
Time Series
Relative Performance
Who Moves First
in sync
LLY and VLTO tend to move at the same time.
After testing 13 timing shifts, the strongest relationship was +0.547 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.045
10 periods · Return correlation when both series rose
Both Falling
-0.446
6 periods · Return correlation when both series fell
Diverging
-0.463
19 periods · Return correlation when series moved apart
R-Squared
30.0%
Share of variance in one series explained by the other.
Trend Agreement
58.8%
How often both series moved in the same direction period-to-period.
Overlap Quality
630
Robust shared window — 630 usable pairs.
Significance
p < 0.001
95% CI: [0.490, 0.600]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
630 paired data points survived the daily window.
Raw input
1,254
630
Normalized
1,254
630
Prepared
1,254
630
Aligned
630
630
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
624
A: 624 / B: 0
Series A
Eli Lilly & Co.
LLY
Market cap 828.2B · 50,000 employees
Stock · 1,254 raw → 1,254 prepared
Series B
Veralto Corporation
VLTO
Market cap 21.8B · 17,000 employees
Stock · 630 raw → 630 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
33
Estimated crossover points between normalized spreads.
Slope
0.0446
Linear regression slope.
Intercept
60.0320
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 6 hours ago · ID: stock-lly-vs-stock-vlto-daily